CA19-9 has been associated with prognosis in CRC patients independent of existing prognostic factors including T stage, N stage, carcinoembryonic antigen (CEA) in some studies [10–21], however, not in other studies [22–26]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.